Business Description
Sunrest Lifescience Ltd
ISIN : INE0PLZ01012
Total Employee Number:
210Compare
Compare
Traded in other countries / regions
SUNREST.India IPO Date
2023-11-20Description
Sunrest Lifescience Ltd is engaged in the trading business of pharmaceutical products, including capsules, tablets, syrups, ointments, gels, mouthwash, and toothpaste on a wholesale and retail basis. Its product portfolio covers categories such as anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental care, anti-inflammatory, nutraceuticals, and more. The company works with a network of suppliers and super suppliers, distributing products to chemists, hospitals, and dispensaries across multiple Indian states. Sunrest relies on both in-house manufacturing through its group company Trilend Pharmaceuticals and third-party manufacturers, emphasizing quality control, and regulatory compliance.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.16 | |||||
Equity-to-Asset | 0.29 | |||||
Debt-to-Equity | 0.86 | |||||
Debt-to-EBITDA | 1.88 | |||||
Interest Coverage | 8.93 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.48 | |||||
Beneish M-Score | -1.9 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 40 | |||||
3-Year EBITDA Growth Rate | 58.1 | |||||
3-Year EPS without NRI Growth Rate | 2.6 | |||||
3-Year Book Growth Rate | 87.2 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 23.99 | |||||
9-Day RSI | 36.51 | |||||
14-Day RSI | 42.74 | |||||
3-1 Month Momentum % | 4.29 | |||||
6-1 Month Momentum % | -9.11 | |||||
12-1 Month Momentum % | -16.87 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.12 | |||||
Quick Ratio | 1.54 | |||||
Cash Ratio | 0.09 | |||||
Days Inventory | 208.05 | |||||
Days Sales Outstanding | 341.13 | |||||
Days Payable | 342.71 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 36.43 | |||||
Operating Margin % | 16.97 | |||||
Net Margin % | 9.19 | |||||
EBITDA Margin % | 25.16 | |||||
FCF Margin % | 4.21 | |||||
OCF Margin % | 7.93 | |||||
ROE % | 18.42 | |||||
ROA % | 5.2 | |||||
ROIC % | 12.58 | |||||
3-Year ROIIC % | 12.23 | |||||
ROC (Joel Greenblatt) % | 23.09 | |||||
ROCE % | 25.14 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 52.65 | |||||
PE Ratio without NRI | 5.91 | |||||
PEG Ratio | 0.07 | |||||
PS Ratio | 0.54 | |||||
PB Ratio | 0.98 | |||||
Price-to-Tangible-Book | 0.98 | |||||
Price-to-Free-Cash-Flow | 9.23 | |||||
Price-to-Operating-Cash-Flow | 5.65 | |||||
EV-to-EBIT | 5.01 | |||||
EV-to-EBITDA | 4.74 | |||||
EV-to-Revenue | 1.19 | |||||
EV-to-FCF | 28.32 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.34 | |||||
Price-to-Graham-Number | 0.43 | |||||
| Price-to-Net-Current-Asset-Value | 1.74 | |||||
Earnings Yield (Greenblatt) % | 19.96 | |||||
FCF Yield % | 7.75 | |||||
Forward Rate of Return (Yacktman) % | -0.43 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sunrest Lifescience Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 368.224 | ||
| EPS (TTM) (₹) | 0.736 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 53.56 | ||
| 14-Day RSI | 42.74 | ||
| 14-Day ATR (₹) | 2.120258 | ||
| 20-Day SMA (₹) | 39.010093 | ||
| 12-1 Month Momentum % | -16.87 | ||
| 52-Week Range (₹) | 24.579193 - 45 | ||
| Shares Outstanding (Mil) | 5.16 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sunrest Lifescience Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sunrest Lifescience Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sunrest Lifescience Ltd Frequently Asked Questions
What is Sunrest Lifescience Ltd(NSE:SUNREST)'s stock price today?
The current price of NSE:SUNREST is ₹38.75. The 52 week high of NSE:SUNREST is ₹45.00 and 52 week low is ₹24.58.
When is next earnings date of Sunrest Lifescience Ltd(NSE:SUNREST)?
The next earnings date of Sunrest Lifescience Ltd(NSE:SUNREST) is .
Does Sunrest Lifescience Ltd(NSE:SUNREST) pay dividends? If so, how much?
Sunrest Lifescience Ltd(NSE:SUNREST) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Sunrest Lifescience Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers